ALFACELL CORP
SC 13G, 1998-02-17
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ALFACELL CORP, SC 13G, 1998-02-17
Next: ALFACELL CORP, SC 13D, 1998-02-17



                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                  SCHEDULE 13G
                                 (Rule 13d-102)
   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),
          (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(B)

                               December 31, 1997
                          Date of Event which Requires
                             filing this Statement

Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ ]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[ ]  Rule 13d-1(d)

                   Under the Securities Exchange Act of 1934

                             (Amendment No._____)*


                              Alfacell Corporation
                                (Name of Issuer)


                          Common Stock, $.001 par value
                         (Title of Class of Securities)


                                   015404106
                                 (CUSIP Number)

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>



CUSIP No. 015404106                   13G                    Page 2  of 6  Pages



- --------------------------------------------------------------------------------
   1.  NAMES OF REPORTING PERSONS
       S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

       KUSLIMA SHOGEN
       

- --------------------------------------------------------------------------------
   2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                             (a)  [  ]
                                                             (b)  [  ]


- --------------------------------------------------------------------------------
   3.  SEC USE ONLY




- --------------------------------------------------------------------------------
   4.  CITIZENSHIP OR PLACE OF ORGANIZATION


       United States

- --------------------------------------------------------------------------------
   NUMBER OF      5.   SOLE VOTING POWER
     SHARES            2,544,587 as of December 31, 1997 (has the right to 
  BENEFICIALLY         acquire 1,245,967 of such shares upon the exercise of 
    OWNED BY           options which are currently exercisable or which will 
      EACH             become exercisable within 60 days of December 31, 1997).
   REPORTING      
     PERSON            2,881,827 as of January 31, 1998 (has the right to 
      WITH             acquire 1,583,207 of such shares upon the exercise of 
                       options which are currently exercisable or which will 
                       become exercisable within 60 days of January 31, 1998). 
                  --------------------------------------------------------------
                  6.   SHARED VOTING POWER
                       -0-
                  --------------------------------------------------------------
                  7.   SOLE DISPOSITIVE POWER
                       2,544,587 as of December 31, 1997 (has the right to     
                       acquire 1,245,967 of such shares upon the exercise of   
                       options which are currently exercisable or which will   
                       become exercisable within 60 days of December 31, 1997).

                       2,881,827 as of January 31, 1998 (has the right to      
                       acquire 1,583,207 of such shares upon the exercise of   
                       options which are currently exercisable or which will   
                       become exercisable within 60 days of January 31, 1998). 
                  --------------------------------------------------------------
                  8.   SHARED DISPOSITIVE POWER
                       -0-
- --------------------------------------------------------------------------------
   9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       2,544,587 as of December 31, 1997 (has the right to acquire 1,245,967 of 
       such shares upon the exercise of options which are currently exercisable 
       or which will become exercisable within 60 days of December 31, 1997).

       2,881,827 as of January 31, 1998 (has the right to acquire 1,583,207 of 
       such shares upon the exercise of options which are currently exercisable 
       or which will become exercisable within 60 days of January 31, 1998).
- --------------------------------------------------------------------------------
  10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

       Not Applicable


<PAGE>


- --------------------------------------------------------------------------------
  11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

       15.8% as of December 31, 1997; 17.5% as of January 31, 1998

- --------------------------------------------------------------------------------
  12.  TYPE OF REPORTING PERSON (See Instructions)*

       IN

- --------------------------------------------------------------------------------

*    SEE INSTRUCTIONS BEFORE FILLING OUT! 

                                  PAGE 2 OF 7


<PAGE>



Item 1 (a)        Name of Issuer:

                                ALFACELL CORPORATION

Item 1 (b)        Address of Issuer's Principal Executive Offices:

                                225 Belleville Avenue
                                Bloomfield, NJ 01003

Item 2 (a)        Name of Person Filing:

                                KUSLIMA SHOGEN

Item 2 (b)        Address of Principal Business Office or, if none,
                           Residence

                                SEE ITEM 1(b) ABOVE

Item 2 (c)        Citizenship:

                                SEE ITEM 4 OF COVER SHEET

Item 2 (d)        Title of Class of Securities:

                                Common Stock, $.001 par value

Item 2 (e)        CUSIP Number:

                                015404106

Item 3.
                                NOT APPLICABLE

Item 4.           Ownership

                  (a)      Amount Beneficially Owned:

                           2,544,587 shares of Common Stock as of December 31,
                           1997 (includes 1,245,967 shares of Common Stock
                           issuable upon exercise of options which are currently
                           exercisable or which will become exercisable within
                           60 days of December 31, 1997).

                           2,881,827 shares of Common Stock as of January 31,
                           1998 (has the right to acquire 1,583,207 of such
                           shares upon the exercise of options which are
                           currently exercisable or which will become
                           exercisable within 60 days of January 31, 1998)


                                   PAGE 3 OF 7

<PAGE>





                  (b)      Percent of Class:

                                15.8% as of December 31, 1997; 17.5% as of 
                                January 31, 1998

                  (c):     Number of shares as to which such person has:

                           (i)     Sole power to vote or to direct the vote: SEE
                                   ITEM 5 OF COVER SHEET.

                           (ii)    Shared power to vote or to direct the vote:
                                   SEE ITEM 6 OF COVER SHEET.

                           (iii)   Sole power to dispose or to direct the
                                   disposition of: SEE ITEM 7 OF COVER SHEET.

                           (iv)    Shared power to dispose or to direct the
                                   disposition of: SEE ITEM 8 OF COVER SHEET.

Item 5.           Ownership of 5% or less of a Class:

     If this Statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial holder of more than
five percent of the class of securities, check the following box.

                                [  ]

Item 6.           Ownership of more than 5% on behalf of another person:

                                NOT APPLICABLE

Item 7.           Identification  and Classification of the Subsidiary which
                  Acquired the Security  being reported on by the Parent Holding
                  Company:

                                NOT APPLICABLE

Item 8.  Identification and Classification of Members of the
                  Group:

                                NOT APPLICABLE


                                   PAGE 4 OF 7


<PAGE>


Item 9.           Notice of Dissolution of Group:

                                NOT APPLICABLE

Item 10.          Certification:

                                NOT APPLICABLE



                                  PAGE 5 OF 7


<PAGE>


                                    SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.



                                                     February 17, 1998
                                                    ----------------------------
                                                        Date


                                                     /s/ KUSLIMA SHOGEN
                                                    ----------------------------
                                                          Signature


                                                     KUSLIMA SHOGEN
                                                    ----------------------------
                                                          Name/Title


                                   PAGE 6 OF 7



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission